Amgen (AMGN) News Today

$272.11 +2.68 (+0.99%)

As of 01/17/2025 04:00 PM Eastern

Compare

Source

Time Period

Amgen: Likely To Be Rangebound (Rating Downgrade)

January 20 at 1:13 PM | seekingalpha.com

Corundum Group Inc. Grows Stock Position in Amgen Inc. (NASDAQ:AMGN)

Corundum Group Inc. increased its position in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 103.3% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 3,996 shares of the medical research company's stock after purchasing an additional 2,

January 20 at 8:32 AM | marketbeat.com

UMB Bank n.a. Lowers Position in Amgen Inc. (NASDAQ:AMGN)

UMB Bank n.a. lessened its stake in Amgen Inc. (NASDAQ:AMGN - Free Report) by 6.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 32,685 shares of the medical research company's stock after se

January 20 at 7:34 AM | marketbeat.com

Sarasin & Partners LLP Sells 286,101 Shares of Amgen Inc. (NASDAQ:AMGN)

Sarasin & Partners LLP lessened its stake in Amgen Inc. (NASDAQ:AMGN - Free Report) by 35.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 532,299 shares of the medical research company's stock after selling

January 20 at 7:15 AM | marketbeat.com

M.E. Allison & CO. Inc. Invests $388,000 in Amgen Inc. (NASDAQ:AMGN)

M.E. Allison & CO. Inc. acquired a new position in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 1,489 shares of the medical research company's stock, val

January 20 at 7:07 AM | marketbeat.com

Willner & Heller LLC Boosts Stock Position in Amgen Inc. (NASDAQ:AMGN)

Willner & Heller LLC boosted its stake in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 81.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,925 shares of the medical research company's stock after buying an additional 1,317 shares durin

January 20 at 6:55 AM | marketbeat.com

Amgen Inc. (NASDAQ:AMGN) Stock Holdings Boosted by Guardian Investment Management

Guardian Investment Management grew its stake in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 29.5% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 18,358 shares of the medical research company's stock after buying an addi

January 20 at 6:21 AM | marketbeat.com

Annex Advisory Services LLC Has $4.11 Million Stock Position in Amgen Inc. (NASDAQ:AMGN)

Annex Advisory Services LLC cut its holdings in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 11.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 15,768 shares of the medical research company's

January 20 at 5:40 AM | marketbeat.com

Amgen Inc. (NASDAQ:AMGN) Shares Purchased by Ameritas Advisory Services LLC

Ameritas Advisory Services LLC lifted its stake in Amgen Inc. (NASDAQ:AMGN - Free Report) by 62.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 10,550 shares of the medical research company's stock after acquiring an additional 4,038 shares

January 20 at 4:37 AM | marketbeat.com

Sax Wealth Advisors LLC Makes New $252,000 Investment in Amgen Inc. (NASDAQ:AMGN)

Sax Wealth Advisors LLC purchased a new stake in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 968 shares of the medical research company's stock, valued at approximately

January 20 at 4:00 AM | marketbeat.com

Brady Martz Wealth Solutions LLC Invests $1.25 Million in Amgen Inc. (NASDAQ:AMGN)

Brady Martz Wealth Solutions LLC acquired a new stake in Amgen Inc. (NASDAQ:AMGN - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 4,662 shares of the medical research company's stock, va

January 19 at 8:45 AM | marketbeat.com

Amgen Inc. (NASDAQ:AMGN) Shares Acquired by Liberty One Investment Management LLC

Liberty One Investment Management LLC boosted its stake in Amgen Inc. (NASDAQ:AMGN - Free Report) by 9.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,895 shares of the medical research company's stock afte

January 19 at 8:02 AM | marketbeat.com

Kelly Financial Services LLC Buys Shares of 14,517 Amgen Inc. (NASDAQ:AMGN)

Kelly Financial Services LLC purchased a new position in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 14,517 shares of the medical research company's stock, valued at appro

January 19 at 7:42 AM | marketbeat.com

Amgen Inc. (NASDAQ:AMGN) Stock Position Trimmed by Aaron Wealth Advisors LLC

Aaron Wealth Advisors LLC lowered its stake in Amgen Inc. (NASDAQ:AMGN - Free Report) by 4.4% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 189,882 shares of the medical research company's stock after selling 8,782 shar

January 19 at 7:01 AM | marketbeat.com

Amgen Inc. (NASDAQ:AMGN) Stock Position Lifted by Merit Financial Group LLC

Merit Financial Group LLC lifted its stake in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 31.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 18,643 shares of the medical res

January 19 at 4:48 AM | marketbeat.com

Why Is Amgen Inc. (AMGN) Among Louis Navellier’s Top Long-term Stock Picks?

January 18 at 3:46 PM | msn.com

Amgen announces FDA approval of Lumakras in combination with Vectibix

January 18 at 10:44 AM | markets.businessinsider.com

HB Wealth Management LLC Buys 1,768 Shares of Amgen Inc. (NASDAQ:AMGN)

HB Wealth Management LLC increased its position in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 4.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 43,854 shares of the medical resear

January 18 at 10:22 AM | marketbeat.com

Cohen Klingenstein LLC Sells 1,750 Shares of Amgen Inc. (NASDAQ:AMGN)

Cohen Klingenstein LLC decreased its stake in Amgen Inc. (NASDAQ:AMGN - Free Report) by 5.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 31,270 shares of the medical research comp

January 18 at 9:31 AM | marketbeat.com

Verity & Verity LLC Raises Stock Position in Amgen Inc. (NASDAQ:AMGN)

Verity & Verity LLC grew its holdings in Amgen Inc. (NASDAQ:AMGN - Free Report) by 5.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 92,490 shares of the medical research company's stock after a

January 18 at 8:51 AM | marketbeat.com

Householder Group Estate & Retirement Specialist LLC Has $412,000 Position in Amgen Inc. (NASDAQ:AMGN)

Householder Group Estate & Retirement Specialist LLC lessened its holdings in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 46.0% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 1,584 shares of the medical research company's stock after selling 1,351 share

January 18 at 5:59 AM | marketbeat.com

Boston Common Asset Management LLC Has $5.66 Million Stake in Amgen Inc. (NASDAQ:AMGN)

Boston Common Asset Management LLC raised its position in Amgen Inc. (NASDAQ:AMGN - Free Report) by 3,060.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 21,711 shares of the medical research company'

January 18 at 5:37 AM | marketbeat.com

Empirical Asset Management LLC Purchases 3,156 Shares of Amgen Inc. (NASDAQ:AMGN)

Empirical Asset Management LLC lifted its position in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 81.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 7,040 shares of the medical research company'

January 18 at 4:59 AM | marketbeat.com

Ritholtz Wealth Management Decreases Holdings in Amgen Inc. (NASDAQ:AMGN)

Ritholtz Wealth Management lowered its stake in Amgen Inc. (NASDAQ:AMGN - Free Report) by 11.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,931 shares of the medical research compan

January 18 at 4:41 AM | marketbeat.com

Amgen: FDA Approves Lumakras (sotorasib) In Combination With Vectibix (panitumumab) For Chemorefractory Kras G12c-mutated Metastatic Colorectal Cancer

January 17, 2025 | finanznachrichten.de

FDA Greenlights Amgen's New Cancer Drug Combo, Boosting Survival for KRAS G12C Patients

January 17, 2025 | uk.finance.yahoo.com

Piper Sandler Reaffirms Their Buy Rating on Amgen (AMGN)

January 17, 2025 | markets.businessinsider.com

Amgen wins FDA nod for Lumakras as a drug combo for colorectal cancer

January 17, 2025 | seekingalpha.com

Piper Sandler maintains Amgen stock Overweight with $310 target

January 17, 2025 | msn.com

FDA Approves Amgen's LUMAKRAS and Vectibix Combination for Metastatic Colorectal Cancer

January 17, 2025 | gurufocus.com

FDA Approves Amgen Treatment For Pretreated Colorectal Cancer With Certain Mutation

January 17, 2025 | benzinga.com

Avanza Fonder AB Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Avanza Fonder AB bought a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 59,122 shares of the medical research company's stock, valued at approximately $15,410,000. Oth